Moomoo AI 已提取核心信息
Aditxt, Inc., a biotech company, has been the subject of a Schedule 13G/A filing with the Securities and Exchange Commission (SEC), dated December 31, 2023. The filing was made by CVI Investments, Inc., based in the Cayman Islands, and Heights Capital Management, Inc., located in Delaware. Both entities are collectively referred to as the 'Reporting Persons' in the document. According to the filing, the Reporting Persons hold an aggregate of 2,066 shares in Aditxt, which represents 0.5% of the company's class of common stock. The shares in question are associated with warrants that are not exercisable if doing so would cause the Reporting Persons' ownership to exceed 4.99% of the total outstanding shares. The filing indicates that Heights Capital Management, Inc., as the investment manager for CVI Investments, Inc., may be deemed to have beneficial ownership of the shares held by CVI Investments, Inc. However, both entities disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest. The filing was certified by Brian Sopinsky, Secretary of both entities, on February 12, 2024.
Aditxt, Inc., a biotech company, has been the subject of a Schedule 13G/A filing with the Securities and Exchange Commission (SEC), dated December 31, 2023. The filing was made by CVI Investments, Inc., based in the Cayman Islands, and Heights Capital Management, Inc., located in Delaware. Both entities are collectively referred to as the 'Reporting Persons' in the document. According to the filing, the Reporting Persons hold an aggregate of 2,066 shares in Aditxt, which represents 0.5% of the company's class of common stock. The shares in question are associated with warrants that are not exercisable if doing so would cause the Reporting Persons' ownership to exceed 4.99% of the total outstanding shares. The filing indicates that Heights Capital Management, Inc., as the investment manager for CVI Investments, Inc., may be deemed to have beneficial ownership of the shares held by CVI Investments, Inc. However, both entities disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest. The filing was certified by Brian Sopinsky, Secretary of both entities, on February 12, 2024.
生物技术公司Aditxt, Inc. 已成为美国证券交易委员会（SEC）于2023年12月31日向美国证券交易委员会（SEC）提交的附表13G/A文件的主体。该文件由总部位于开曼群岛的CVI Investments, Inc.和位于特拉华州的Heights Capital Management, Inc.提交。这两个实体在文件中统称为 “举报人”。根据该文件，申报人共持有Aditxt的2,066股股票，占该公司普通股类别的0.5％。如果这样做会导致申报人所有权超过已发行股份总额的4.99％，则有关股份与不可行使的认股权证有关。该文件显示，作为CVI Investments, Inc. 的投资管...展开全部
生物技术公司Aditxt, Inc. 已成为美国证券交易委员会（SEC）于2023年12月31日向美国证券交易委员会（SEC）提交的附表13G/A文件的主体。该文件由总部位于开曼群岛的CVI Investments, Inc.和位于特拉华州的Heights Capital Management, Inc.提交。这两个实体在文件中统称为 “举报人”。根据该文件，申报人共持有Aditxt的2,066股股票，占该公司普通股类别的0.5％。如果这样做会导致申报人所有权超过已发行股份总额的4.99％，则有关股份与不可行使的认股权证有关。该文件显示，作为CVI Investments, Inc. 的投资管理公司的Heights Capital Management, Inc. 可能被视为拥有CVI Investments, Inc.持有的股票的实益所有权。但是，两家实体均放弃对这些股票的实益所有权，除非其金钱利益。该文件于2024年2月12日由两个实体的秘书布莱恩·索平斯基认证。
有用
没用
